News from the healthcare data industry
Foundation Medicine’s tissue-based test is the first and only comprehensive genomic profiling test to be approved as a companion diagnostic for a third group of targeted therapies March 17, 2022...
Powered by Komodo’sHealthcare Map™, Provider Finder connects patients with top specialists by geography and expertise March 16, 2022 08:00 AM Eastern Daylight Time WASHINGTON–(BUSINESS WIRE)–Today, Komodo Health and Fight Colorectal...
Tyra Biosciences supported study investigates if non-invasive blood and urine samples provide biomarkers to assess clinical response to erdafitinib treatment OAKLAND, CALIFORNIA, UNITED STATES, March 10, 2022 /EINPresswire.com/ — Today,...
AI-driven discovery platform enables new way to find novel pathways as well as progress towards identifying patients who may better respond to drugs in the clinic Preclinical data highlights the...
New partnership allows for a 40,000+ patient dataset to unlock new insights into cancer treatments and outcomes.xCures and BioSpark are driving a fundamental shift in the quality, utility, and value...
By Anastassia Gliadkovskaya Mar 1, 2022 12:45pmKomodo Health Black patients wait longer for diagnosis and treatment of colorectal cancer than their white counterparts do, a new study has revealed. The analysis was conducted...
Foundation Medicine’s tissue-based comprehensive genomic profiling test is now the first and only FDA-approved companion diagnostic to aid in identifying patients with MSI-H solid tumors who may benefit from immunotherapy...
ZURICH, Feb. 21, 2022 /PRNewswire/ — BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced a new data partnership with Japan’s Mitsubishi Space Software Co. Ltd. (Mitsubishi), one of the country’s...
New research led by Yale Cancer Center revealed White patients had significantly more telemedicine visits compared with Black patients for hematologic cancer care during the COVID-19 pandemic. Also, in-person visit rates for...
February 15, 2022 06:56 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, today announced that the U.S. Food and Drug Administration (FDA)...